AESTHETIC FILLERS MARKET ANALYSIS

Aesthetic Fillers Market, By Product Type (Absorbable and Non-absorbable), By Material Type (Polymers and Particles, Collagen, and Hyaluronic Acid), By Application (Facial Line Correction and Wrinkles, Face Lift, Lip Treatment, and Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Oct 2022
Code : CMI5267
Pages :170
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Global Aesthetic Fillers Market: Key Developments

In June 2020, AbbVie (Allergan Aesthetics) received the Food and Drug Administration (FDA) approval for its product JUVÉDERM VOLUMA XC for the augmentation of the chin region to improve the chin profile in adults over the age of 21.

In March 2020, Sinclair Pharma (Sinclair) announced exclusive worldwide licence agreement for ground-breaking range of injectable hyaluronic acid products.

In April 2019, Merz announced the launch of Belotero Revive, a dermal filler containing a unique combination of hyaluronic acid and glycerol, designed to improve hydration, elasticity, and firmness of the skin and to address the appearance of fine lines.

Global Aesthetic Fillers Market: Key Companies Insights

The global aesthetic fillers market is highly competitive. This is attributed to the increase in attention on facial aesthetics among older population, as a result, market players are focusing on launching novel products in the market.

Some of the key players in the global aesthetic fillers market are Teoxane Laboratories, Suneva Medical Inc., Sinclair Pharma, Merz Pharma, Laboratories Vivacy SAS, Vital Esthetique, Galderma Pharma SA, and Allergan PLC (Abbvie Inc.), among others.